GLP-1 receptor agonist medications, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro), can be injected into the upper arm as an approved subcutaneous injection site
Antidiabetic drugs, including intranasally administered insulin, as well as GLP-1RAs, modify the processes linking T2DM with cognitive impairment [29]
If you experience any suspected side effects from your medications, report them to the MHRA Yellow Card Scheme, which helps monitor the safety of medicines in the UK
Understanding the Distinction There are two separate clinical scenarios that coders often confuse: Scenario A: Steroid-induced hyperglycemia (not yet diabetes) The patient has elevated blood sugar in response to steroids, but the physician has not documented a formal diabetes diagnosis
For example, if a costly biologic is under medical benefit, the patient might pay 20% coinsurance on a $10,000 infusion (i.e